TW202119028A - Method for identifying dermal sheath cup cells - Google Patents

Method for identifying dermal sheath cup cells Download PDF

Info

Publication number
TW202119028A
TW202119028A TW109124757A TW109124757A TW202119028A TW 202119028 A TW202119028 A TW 202119028A TW 109124757 A TW109124757 A TW 109124757A TW 109124757 A TW109124757 A TW 109124757A TW 202119028 A TW202119028 A TW 202119028A
Authority
TW
Taiwan
Prior art keywords
cell
cell composition
cells
root sheath
hair bulb
Prior art date
Application number
TW109124757A
Other languages
Chinese (zh)
Inventor
小出沙也加
石松弓子
相馬勤
Original Assignee
日商資生堂股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商資生堂股份有限公司 filed Critical 日商資生堂股份有限公司
Publication of TW202119028A publication Critical patent/TW202119028A/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/10Detection of antigens from microorganism in sample from host

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

There is need for a method for allowing management of the quality of a cellular composition containing dermal sheath cup cells when providing the cellular composition in a hair regenerative therapy. The management of the quality of a cellular composition containing dermal sheath cup cells has so far been performed indirectly by conducting a keratinocyte negative test or a melanocyte negative test. There is a demand for a simpler, easier, and more direct method. According to the present invention, the use of CD13, CD90, CD10, CD29, CD105, CD49b, and NG2, which are cell surface markers enabling identification of dermal sheath cup cells through discrimination from melanocytes and keratinocytes, allows identification of dermal sheath cup cells, whereby the quality of a cellular composition containing dermal sheath cup cells can be managed.

Description

鑑定毛球部毛根鞘細胞之方法Method for identifying hair root sheath cells of hair bulb

本發明係關於一種毛髮再生之細胞治療之技術領域。更具體而言,本發明係關於一種於毛髮再生之細胞治療中使用之鑑定毛球部毛根鞘細胞之方法。The present invention relates to the technical field of cell therapy for hair regeneration. More specifically, the present invention relates to a method for identifying hair bulb root sheath cells used in cell therapy for hair regeneration.

作為脫髮症或毛髮稀少之治療,主要進行藥劑之投予,但需要持續投予,另一方面,亦存在因對象不同而無法獲得充分效果之情況。另一方面,期待使自對象之頭皮組織採取之可成為毛髮之細胞增生,並藉由自體移植移回至對象之頭皮,藉此安全性更高且有效地使毛髮再生。毛髮再生所使用之細胞可使用毛乳頭細胞、毛球部毛根鞘細胞等。As a treatment for alopecia or hair thinning, drug administration is mainly carried out, but continuous administration is required. On the other hand, there are cases where sufficient effects cannot be obtained depending on the target. On the other hand, it is expected that the cells taken from the scalp tissue of the subject can be proliferated and transferred back to the scalp of the subject by autologous transplantation, so as to regenerate the hair more safely and effectively. As the cells used for hair regeneration, dermal papilla cells, hair bulb root sheath cells, etc. can be used.

利用自體移植技術之毛髮再生治療之實用化臨近。伴隨此,為了更加提高安全性及有效性而實現穩定之毛髮再生,細胞培養物之品質管理變得重要。於將毛球部毛根鞘細胞用於移植之情形時,存在於其採取部位附近之黑色素細胞及角質形成細胞有可能混入。因此,針對培養毛球部毛根鞘細胞並使之增生所獲得之細胞組合物,對在移植至對象之前黑色素細胞及角質形成細胞之混入進行檢查。在此之前,為了檢測角質形成細胞之混入而進行了如下試驗方法,該試驗方法係藉由利用流式細胞儀之分析而否定角質形成細胞之存在,並且藉由酪胺酸酶與基質之反應性而否定黑色素細胞之存在。The practical application of hair regrowth therapy using autologous transplantation technology is approaching. Along with this, in order to further improve safety and effectiveness and achieve stable hair regeneration, the quality control of cell cultures has become important. When the hair bulb root sheath cells are used for transplantation, the melanocytes and keratinocytes existing near the harvesting site may be mixed. Therefore, the cell composition obtained by culturing and proliferating hair root sheath cells of the hair bulb is examined for the incorporation of melanocytes and keratinocytes before transplantation into the subject. Prior to this, in order to detect the incorporation of keratinocytes, the following test method was carried out. The test method was to deny the presence of keratinocytes by analysis by flow cytometry, and by the reaction of tyrosinase and matrix Sex and deny the existence of melanocytes.

為了識別細胞種類,一般使用細胞表面標記物。主要之細胞表面標記物係由作為國際分類之CD(Cluster of Differentiation,聚類分化群)分類來確定。細胞表面標記物有助於識別細胞種類。然而,即便於某種細胞種類中表現,只要於混入之細胞種類中亦有表現,便無法用於識別。又,由於亦存在視細胞狀態而細胞表面標記物產生變化之情況,故至今為止未特定出識別移植前之毛球部毛根鞘細胞而與其他細胞種類區分開之標記物。 [先前技術文獻] [非專利文獻]In order to identify cell types, cell surface markers are generally used. The main cell surface markers are determined by the CD (Cluster of Differentiation) classification as an international classification. Cell surface markers help identify cell types. However, even if it is expressed in a certain cell type, as long as it is also expressed in the mixed cell type, it cannot be used for identification. In addition, since there are also cases where the cell surface markers change depending on the cell state, so far, no markers have been identified that distinguish the hair bulb root sheath cells before transplantation and distinguish them from other cell types. [Prior Technical Literature] [Non-Patent Literature]

[非專利文獻1]Lee et al., J. DERMATOL 2006; 155: 858-860 [非專利文獻2]Poblet et al., J. DERMATOL 2008; 159: 646-652 [非專利文獻3]Sorrel et al., Exp Dermatol 2003; 12: 315 [非專利文獻4]Park et al., J Cutan Pathol. 2017; 44: 909-914. [非專利文獻5]Ernst et al., PLoS One. 2013; 8 (12) [非專利文獻6]Huang et al., Sci Rep. 2016; 6 [非專利文獻7]Dominici et al., Cytotherapy 2006; 8: 315-317 [非專利文獻8]Wang et al., J Invest Dermatol. 2014; 134: 736-745[Non-Patent Document 1] Lee et al., J. DERMATOL 2006; 155: 858-860 [Non-Patent Document 2] Poblet et al., J. DERMATOL 2008; 159: 646-652 [Non-Patent Document 3] Sorrel et al., Exp Dermatol 2003; 12: 315 [Non-Patent Document 4] Park et al., J Cutan Pathol. 2017; 44: 909-914. [Non-Patent Document 5] Ernst et al., PLoS One. 2013; 8 (12) [Non-Patent Document 6] Huang et al., Sci Rep. 2016; 6 [Non-Patent Document 7] Dominici et al., Cytotherapy 2006; 8: 315-317 [Non-Patent Document 8] Wang et al., J Invest Dermatol. 2014; 134: 736-745

[發明所欲解決之問題][The problem to be solved by the invention]

於先前所進行之黑色素細胞及角質形成細胞之否定試驗中,陽性對照之製備、或試驗之實施需要巨大之勞力及時間。又,該否定試驗充其量為否定角質形成細胞及黑色素細胞之混入之方法,存在並不直接鑑定毛球部毛根鞘細胞(Dermal Sheath Cup Cells(DSCC))之問題。因此,業界尋求一種能夠更簡便地對包含毛球部毛根鞘細胞之細胞組合物進行品質管理之方法。 [解決問題之技術手段]In the previous negative test of melanocytes and keratinocytes, the preparation of the positive control or the implementation of the test requires a lot of labor and time. In addition, this negative test is at best a method to deny the incorporation of keratinocytes and melanocytes, and there is a problem that it does not directly identify the root sheath cells (Dermal Sheath Cup Cells (DSCC)) of the hair bulb. Therefore, the industry seeks a method that can more easily control the quality of a cell composition containing hair bulb root sheath cells. [Technical means to solve the problem]

本發明人等對於包含毛球部毛根鞘細胞之細胞組合物中鑑定毛球部毛根鞘細胞之手法進行了銳意研究,結果發現一種能夠識別黑色素細胞及/或角質形成細胞、及毛球部毛根鞘細胞之細胞表面標記物,從而完成了本發明。因此,本發明係關於以下者: [1]一種鑑定毛球部毛根鞘細胞之方法,其係於包含毛球部毛根鞘細胞之細胞組合物中鑑定毛球部毛根鞘細胞之方法,該方法包括對選自由CD13、CD90、CD10、CD29、CD105、CD49b及NG2所組成之群中之至少1種細胞表面標記物進行檢測。 [2]如項目1所記載之方法,其中上述細胞表面標記物係選自由CD13、CD90、CD10、CD29、CD105、及NG2所組成之群,且識別毛球部毛根鞘細胞而與上述細胞組合物中所包含之角質形成細胞區分開。 [3]如項目1所記載之方法,其中上述細胞表面標記物係選自由CD13、CD90、CD29、及CD49b所組成之群,且識別毛球部毛根鞘細胞而與上述細胞組合物中所包含之黑色素細胞區分開。 [4]如項目1所記載之方法,其中上述細胞表面標記物係選自由CD13、CD90、及CD29所組成之群,且識別毛球部毛根鞘細胞而與上述細胞組合物中所包含之黑色素細胞及角質形成細胞區分開。 [5]如項目1至4中任一項所記載之方法,其中上述細胞表面標記物係選自由CD13及CD90所組成之群。 [6]如項目1至5中任一項所記載之方法,其中上述細胞表面標記物係藉由流式細胞分析來檢測。 [7]如項目1至6中任一項所記載之方法,其中上述細胞組合物係用於毛髮再生之細胞組合物。 [8]如項目1至7中任一項所記載之方法,其中上述細胞組合物包含經過培養之毛球部毛根鞘細胞。 [9]如項目1至8中任一項所記載之方法,其中細胞組合物係冷凍保存前或冷凍保存後之細胞組合物。 [10]如項目9所記載之方法,其中細胞組合物係冷凍保存後之細胞組合物。 [11]一種確定細胞組合物之品質之方法,其藉由如項目1至10中任一項所記載之方法,於包含毛球部毛根鞘細胞之細胞組合物中鑑定毛球部毛根鞘細胞,藉此確定細胞組合物之品質。 [12]一種品質得到管理之細胞組合物之製造方法,其包括以下步驟: 藉由如項目11所記載之確定細胞組合物之品質之方法來確定包含毛球部毛根鞘細胞之細胞組合物之品質,並且 除去規定品質以下之細胞組合物。 [發明之效果]The present inventors conducted intensive research on the method of identifying hair bulb root sheath cells in a cell composition containing hair bulb root sheath cells, and found a method capable of identifying melanocytes and/or keratinocytes, and hair bulb root sheath cells. The cell surface marker of sheath cells has completed the present invention. Therefore, the present invention relates to the following: [1] A method for identifying hair bulb root sheath cells, which is a method of identifying hair bulb root sheath cells in a cell composition comprising hair bulb root sheath cells, the method comprising selecting from CD13, CD90, CD10 At least one cell surface marker in the group consisting of CD29, CD105, CD49b and NG2 can be detected. [2] The method according to item 1, wherein the cell surface marker is selected from the group consisting of CD13, CD90, CD10, CD29, CD105, and NG2, and the hair bulb root sheath cells are identified and combined with the above cells The keratinocytes contained in the product are distinguished from each other. [3] The method according to item 1, wherein the cell surface marker is selected from the group consisting of CD13, CD90, CD29, and CD49b, and the hair bulb root sheath cells are recognized and are included in the cell composition The melanocytes are distinguished. [4] The method according to item 1, wherein the cell surface marker is selected from the group consisting of CD13, CD90, and CD29, and the hair bulb root sheath cell is recognized and the melanin contained in the cell composition Cells and keratinocytes are distinguished. [5] The method according to any one of items 1 to 4, wherein the cell surface marker is selected from the group consisting of CD13 and CD90. [6] The method according to any one of items 1 to 5, wherein the cell surface marker is detected by flow cytometry. [7] The method according to any one of items 1 to 6, wherein the above-mentioned cell composition is a cell composition for hair regeneration. [8] The method according to any one of items 1 to 7, wherein the cell composition includes cultured hair bulb root sheath cells. [9] The method according to any one of items 1 to 8, wherein the cell composition is a cell composition before or after cryopreservation. [10] The method according to item 9, wherein the cell composition is a cell composition after cryopreservation. [11] A method for determining the quality of a cell composition by identifying hair bulb root sheath cells in a cell composition containing hair bulb root sheath cells by the method described in any one of items 1 to 10 To determine the quality of the cell composition. [12] A method for manufacturing a cell composition with managed quality, which includes the following steps: Determine the quality of the cell composition containing hair bulb root sheath cells by the method for determining the quality of the cell composition as described in item 11, and Remove the cell composition below the specified quality. [Effects of Invention]

藉由本發明,能夠以更短之時間及較少之勞力實現包含毛球部毛根鞘細胞之細胞組合物之品質管理。With the present invention, the quality control of the cell composition containing the hair bulb root sheath cells can be realized in a shorter time and less labor.

本發明係關於一種於包含毛球部毛根鞘細胞之細胞組合物中鑑定毛球部毛根鞘細胞之方法。更具體而言,包括於包含毛球部毛根鞘細胞之細胞組合物中對選自由CD13、CD90、CD10、CD29、CD105、CD49b及NG2所組成之群中之至少1種細胞表面標記物進行檢測。該等細胞表面標記物係於毛球部毛根鞘細胞中表現。該等細胞表面標記物可單獨使用,亦可組合使用。The present invention relates to a method for identifying hair bulb root sheath cells in a cell composition containing hair bulb root sheath cells. More specifically, the detection of at least one cell surface marker selected from the group consisting of CD13, CD90, CD10, CD29, CD105, CD49b, and NG2 is included in a cell composition containing hair bulb root sheath cells . These cell surface markers are expressed in the hair root sheath cells of the hair bulb. These cell surface markers can be used alone or in combination.

於上述細胞表面標記物中,角質形成細胞具有CD49b,CD49b並不適於角質形成細胞與DSCC之分離。因此,就於包含毛球部毛根鞘細胞之細胞組合物中識別毛球部毛根鞘細胞與角質形成細胞之觀點而言,使用選自由CD13、CD90、CD10、CD29、CD105、及NG2所組成之群中之至少一種細胞表面標記物。另一方面,CD29及NG2於DSCC中之表現稍低(約90%),另一方面,於角質形成細胞中可見表現(15.7%、5.34%)。CD105雖於角質形成細胞中之表現較低(0.56%),但於DSCC中之表現較低(84.4%)。因此,於更佳態樣中,使用選自由CD13、CD90、及CD10所組成之群中之至少一種細胞表面標記物。該等細胞表面標記物可單獨使用,亦可組合使用。Among the above-mentioned cell surface markers, keratinocytes have CD49b, and CD49b is not suitable for the separation of keratinocytes and DSCCs. Therefore, from the viewpoint of identifying hair bulb root sheath cells and keratinocytes in a cell composition containing hair bulb root sheath cells, use selected from the group consisting of CD13, CD90, CD10, CD29, CD105, and NG2 At least one cell surface marker in the population. On the other hand, the performance of CD29 and NG2 in DSCC is slightly lower (about 90%). On the other hand, the performance of CD29 and NG2 is seen in keratinocytes (15.7%, 5.34%). Although CD105 has a lower performance in keratinocytes (0.56%), it has a lower performance in DSCC (84.4%). Therefore, in a better aspect, at least one cell surface marker selected from the group consisting of CD13, CD90, and CD10 is used. These cell surface markers can be used alone or in combination.

於上述細胞表面標記物中,黑色素細胞具有CD10、CD105、NG2,該等標記物並不適於黑色素細胞與DSCC之分離。因此,就於包含毛球部毛根鞘細胞之細胞組合物中識別毛球部毛根鞘細胞與黑色素細胞之觀點而言,使用選自由CD13、CD90、CD29、及CD49b所組成之群中之至少一種細胞表面標記物。另一方面,CD29及CD49b於DSCC中之表現相對較低(92.4%、96.7%),且於黑色素細胞中亦可見一定程度表現(17.9%、1.81%)。因此,於更佳之態樣中,使用選自由CD13及CD90所組成之群中之至少一種細胞表面標記物。該等細胞表面標記物可單獨使用,亦可組合使用。Among the above-mentioned cell surface markers, melanocytes have CD10, CD105, and NG2, and these markers are not suitable for the separation of melanocytes from DSCC. Therefore, in terms of identifying hair bulb root sheath cells and melanocytes in a cell composition containing hair bulb root sheath cells, at least one selected from the group consisting of CD13, CD90, CD29, and CD49b is used Cell surface markers. On the other hand, the performance of CD29 and CD49b in DSCC is relatively low (92.4%, 96.7%), and a certain degree of performance (17.9%, 1.81%) can also be seen in melanocytes. Therefore, in a better aspect, at least one cell surface marker selected from the group consisting of CD13 and CD90 is used. These cell surface markers can be used alone or in combination.

於包含毛球部毛根鞘細胞之細胞組合物中,就識別毛球部毛根鞘細胞而與黑色素細胞及角質形成細胞兩者區分開之觀點而言,使用選自由CD13、CD90、及CD29所組成之群中之細胞表面標記物。更佳為使用選自由CD13及CD90所組成之群中之至少一種細胞表面標記物。In the cell composition containing hair bulb root sheath cells, in terms of identifying hair bulb root sheath cells and distinguishing them from melanocytes and keratinocytes, a composition selected from CD13, CD90, and CD29 is used Cell surface markers in the group. It is more preferable to use at least one cell surface marker selected from the group consisting of CD13 and CD90.

於本發明中,細胞表面標記物係指存在於細胞表面之抗原。尤其是可藉由CD編號來表示,該CD編號係由作為國際分類之CD分類來進行分類並確定。CD分類原本為單株抗體之分類,但亦可用於單株抗體所識別之表面抗原之名稱。與所需之細胞表面標記物特異性地結合之抗體能夠自各經銷商處獲取。In the present invention, a cell surface marker refers to an antigen present on the surface of a cell. In particular, it can be represented by the CD number, which is classified and determined by the CD classification as an international classification. The CD classification was originally the classification of monoclonal antibodies, but it can also be used to name the surface antigens recognized by monoclonal antibodies. Antibodies that specifically bind to the required cell surface markers can be obtained from various distributors.

因此,於本發明之另一態樣中,本發明亦可關於一種使用選自由CD13、CD90、CD10、CD29、CD105、CD49b及NG2所組成之群中之至少1種單株抗體來鑑定毛球部毛根鞘細胞之方法。可使用該等單株抗體並藉由任意之免疫手法來進行檢測。Therefore, in another aspect of the present invention, the present invention can also relate to the use of at least one monoclonal antibody selected from the group consisting of CD13, CD90, CD10, CD29, CD105, CD49b and NG2 to identify hair bulbs The method of hair root sheath cells. These monoclonal antibodies can be used and detected by any immunization technique.

本發明中所提及之細胞表面標記物可以任意組合來使用,例如亦可將2種、3種、4種、或4種以上之細胞表面標記物組合來使用。作為一例,就將識別力較高之細胞表面標記物組合之觀點而言,可使用CD13與CD90、CD13與CD29、CD29與CD90之組合。就以一單株抗體高精度地識別角質形成細胞,以另一單株抗體高精度地識別黑色素細胞之觀點而言,可使用CD10與CD13、CD10與CD90、CD10與CD29、CD10與CD49b、CD13與CD29、CD13與CD49b、CD90與CD29、CD90與CD49b、CD29與CD49b、CD105與CD13、CD105與CD90、CD105與CD29、CD105與CD49b、NG2與CD10、NG2與CD13、NG2與CD90、NG2與CD29、NG2與CD49b之組合。作為3種之組合,可使用CD13、CD90及CD29。The cell surface markers mentioned in the present invention can be used in any combination, for example, two, three, four, or more than four cell surface markers can also be used in combination. As an example, from the viewpoint of combining cell surface markers with higher recognition ability, a combination of CD13 and CD90, CD13 and CD29, and CD29 and CD90 can be used. In terms of using one monoclonal antibody to recognize keratinocytes with high precision and another monoclonal antibody to recognize melanocytes with high precision, CD10 and CD13, CD10 and CD90, CD10 and CD29, CD10 and CD49b, and CD13 can be used. And CD29, CD13 and CD49b, CD90 and CD29, CD90 and CD49b, CD29 and CD49b, CD105 and CD13, CD105 and CD90, CD105 and CD29, CD105 and CD49b, NG2 and CD10, NG2 and CD13, NG2 and CD90, NG2 and CD29 , NG2 and CD49b combination. As a combination of 3 types, CD13, CD90 and CD29 can be used.

細胞表面標記物可使用本技術領域中已知之任意手法來檢測。作為一例,可藉由使用會與各細胞表面標記物結合之標記抗體之流式細胞分析法來進行檢測。於檢測組合之情形時,可藉由使用單株抗體而實現檢測,該單株抗體係使用具有不同吸收波長及激發波長之螢光標記進行過標記者。此種螢光標記之組合為業者所周知,可適當進行選擇。作為一例,可使用FITC(Fluorescein Isothiocyanate,螢光異硫氰酸鹽)與PE(Phycoerythrin,藻紅蛋白螢光染料)之組合。於進行流式細胞分析法之情形時,基於所檢測出之螢光標記來分取細胞,藉此可獲得實質上僅包含毛球部毛根鞘細胞之細胞組合物。The cell surface markers can be detected using any method known in the art. As an example, detection can be performed by flow cytometry using labeled antibodies that bind to various cell surface markers. In the case of detecting combinations, detection can be achieved by using monoclonal antibodies, which are labeled with fluorescent labels with different absorption wavelengths and excitation wavelengths. Such a combination of fluorescent markers is well known to the industry and can be selected appropriately. As an example, a combination of FITC (Fluorescein Isothiocyanate) and PE (Phycoerythrin) can be used. In the case of the flow cytometry method, the cells are sorted based on the detected fluorescent markers, thereby obtaining a cell composition containing substantially only the root sheath cells of the hair bulb.

於本發明中,細胞組合物係指包含細胞之任意組合物。本發明之細胞組合物尤其是為用於毛髮再生之細胞組合物或用於頭皮注入之細胞組合物。本發明之細胞組合物主要包含毛球部毛根鞘細胞,進而包含微量之角質形成細胞、黑色素細胞,還可包含其他細胞。本發明之用於毛髮再生之細胞組合物可藉由如下方式獲得:藉由將人類之包含毛球部之樣本切開而與毛乳頭細胞區分開,取得毛球部毛根鞘細胞,並根據情形進行培養。因此,用於毛髮再生之細胞組合物實質上不包含毛乳頭細胞。另一方面,由於在包含毛球部之樣本毛球部毛根鞘細胞之附近存在角質形成細胞及黑色素細胞,故於包含毛球部毛根鞘細胞之細胞組合物中可包含角質形成細胞及黑色素細胞。並未刻意限定,但供於本發明之鑑定方法之細胞組合物係使毛球部毛根鞘細胞增生(或濃縮)後之細胞組合物,通常包含細胞集群之30%以上、較佳為50%以上、進而更佳為70%以上之毛球部毛根鞘細胞。對於此種包含毛球部毛根鞘細胞之細胞組合物,可使用本發明之鑑定方法或品質確定方法。藉此,可確定細胞組合物中所包含之毛球部毛根鞘細胞存在細胞集群所需之比率以上,作為一例,係以90%以上存在,而可保證細胞組合物之品質。本發明之細胞組合物可為培養細胞所獲得之細胞組合物,於細胞組合物中,可包含除細胞以外之成分、例如培養基等,且根據情形亦可包含冷凍保護劑或細胞活化劑等。In the present invention, a cell composition refers to any composition containing cells. The cell composition of the present invention is particularly a cell composition for hair regeneration or a cell composition for scalp injection. The cell composition of the present invention mainly contains hair bulb root sheath cells, and further contains a small amount of keratinocytes, melanocytes, and may also contain other cells. The cell composition for hair regeneration of the present invention can be obtained by cutting a human hair bulb-containing sample to distinguish it from hair papilla cells, obtaining hair bulb root sheath cells, and proceeding according to the situation bring up. Therefore, the cell composition for hair regeneration does not substantially contain dermal papilla cells. On the other hand, since keratinocytes and melanocytes exist in the vicinity of the hair bulb root sheath cells of the sample including the hair bulb portion, the cell composition containing hair bulb root sheath cells may include keratinocytes and melanocytes . It is not specifically limited, but the cell composition used in the identification method of the present invention is the cell composition after proliferating (or condensing) hair bulb root sheath cells, and usually contains more than 30% of the cell population, preferably 50% Above, more preferably more than 70% of hair bulb root sheath cells. For such a cell composition containing hair bulb root sheath cells, the identification method or quality determination method of the present invention can be used. By this, it can be determined that the hair bulb root sheath cells contained in the cell composition are more than the ratio required for cell clusters. As an example, they are more than 90%, and the quality of the cell composition can be guaranteed. The cell composition of the present invention may be a cell composition obtained by culturing cells. The cell composition may include components other than the cells, such as a culture medium, etc., and may also include a cryoprotectant or a cell activator according to the situation.

於又一態樣中,本發明亦可關於一種品質得到管理之包含毛球部毛根小細胞之細胞組合物之製造方法,其藉由確定包含毛球部毛根鞘細胞之細胞組合物之品質而製造品質得到管理之包含毛球部毛根小細胞之細胞組合物。該製造方法具體而言,於包含毛球部毛根鞘細胞之細胞組合物中對選自由CD13、CD90、CD10、CD29、CD105、CD49b及NG2所組成之群中之至少1種細胞表面標記物進行檢測,確定細胞組合物之品質並去除規定品質以下之細胞組合物,藉此可取得品質得到管理之包含毛球部毛根小細胞之細胞組合物。關於品質,作為一例,可藉由將毛球部毛根小細胞之存在比率與規定之閾值進行比較來確定。作為規定之閾值,例如可使用90%、較佳為95%、進而較佳為97%、進而更佳為99%。In another aspect, the present invention may also be related to a method for manufacturing a cell composition containing hair bulb root small cells whose quality is managed by determining the quality of the cell composition containing hair bulb root sheath cells. Produces a cell composition containing hair root small cells of the hair bulb with controlled quality. The manufacturing method specifically involves performing at least one cell surface marker selected from the group consisting of CD13, CD90, CD10, CD29, CD105, CD49b, and NG2 in a cell composition containing hair bulb root sheath cells. Detect and determine the quality of the cell composition and remove the cell composition below the prescribed quality, thereby obtaining the cell composition containing the hair root small cells of the hair bulb with controlled quality. Regarding quality, as an example, it can be determined by comparing the presence ratio of hair root small cells in the hair bulb with a predetermined threshold. As the predetermined threshold value, for example, 90%, preferably 95%, more preferably 97%, and still more preferably 99% can be used.

於本發明中,在包含毛球部毛根鞘細胞之細胞組合物中可鑑定出毛球部毛根鞘細胞。毛球部毛根鞘細胞之鑑定係指識別毛球部毛根鞘細胞而與細胞組合物中所包含之其他細胞種類區分開。因此,只要可與包含毛球部毛根鞘細胞之細胞組合物中可包含之不期望之細胞、例如角質形成細胞及/或黑色素細胞區分開識別出毛球部毛根鞘細胞即可。In the present invention, hair bulb root sheath cells can be identified in the cell composition containing hair bulb root sheath cells. The identification of hair bulb root sheath cells refers to identifying hair bulb root sheath cells to distinguish them from other cell types contained in the cell composition. Therefore, as long as the hair bulb root sheath cells can be distinguished from the undesired cells that may be included in the cell composition containing the hair bulb root sheath cells, such as keratinocytes and/or melanocytes.

於毛髮再生之細胞治療中,有時在與取得組織並移植所培養之細胞之臨床現場不同之場合中對細胞進行加工培養。作為一例,細胞之加工培養係於另外設置之細胞加工培養設施中進行。包含於細胞加工培養設施中所製作之毛球部毛根鞘細胞之組合物係在進行過品質檢查後送至臨床現場。本發明之包含毛球部毛根鞘細胞之細胞組合物中之毛球部毛根鞘細胞之鑑定方法通常於細胞加工培養後且出貨前進行,亦可於細胞加工、即自組織分離細胞後且冷凍保存前、冷凍保存後進行。一般而言,冷凍保存後之細胞組合物中之細胞中代謝會產生變化,因此細胞表面標記物亦可能變化。另一方面,本發明中所特定出之細胞表面標記物、尤其是CD90及CD13即便於剛冷凍保存後,對於DSCC之識別力亦未顯示出差異(未登載資料),而可用於冷凍保存前及冷凍保存後之任一細胞組合物。In cell therapy for hair regeneration, cells are sometimes processed and cultured in a different setting from the clinical site where the tissue is obtained and the cultured cells are transplanted. As an example, the processing and culturing of cells is carried out in a separate cell processing and culturing facility. The composition containing the hair bulb root sheath cells produced in the cell processing and culture facility is sent to the clinical site after quality inspection. The method for identifying hair bulb root sheath cells in the cell composition comprising hair bulb root sheath cells of the present invention is usually carried out after cell processing and culture and before shipment. It can also be performed after cell processing, that is, after cells are separated from tissues and Carry out before cryopreservation and after cryopreservation. Generally speaking, the metabolism of cells in the cell composition after cryopreservation will change, so the cell surface markers may also change. On the other hand, the cell surface markers specified in the present invention, especially CD90 and CD13, showed no difference in the discrimination of DSCC even after cryopreservation (data not published), and can be used before cryopreservation. And any cell composition after cryopreservation.

於選擇本發明中所使用之細胞表面標記物時,將8種表面抗原(CD10、CD13、CD29、CD49b、CD90、CD105、CD274、及NG2)作為研究對象。所研究之8種標記物於毛球部毛根鞘細胞中之表現在此之前未有報告。對該等標記物之見解如下所述。When selecting the cell surface markers used in the present invention, eight surface antigens (CD10, CD13, CD29, CD49b, CD90, CD105, CD274, and NG2) were used as the research objects. The performance of the eight markers studied in the hair bulb root sheath cells has not been reported before. The findings on these markers are as follows.

CD10係於神經系統、造血系統細胞等各種組織中表現。報告有於毛囊中CD10於真皮毛根鞘(Dermal Sheath)中表現(非專利文獻1:Lee et al., J. DERMATOL 2006; 155: 858-860及非專利文獻2:Poblet et al., J. DERMATOL 2008; 159: 646-652)。又,該CD10為人類急性淋巴母細胞白血病之共通抗原,作為人類膜結合中性內肽酶(NEP)為人所知。CD10 is expressed in various tissues such as nervous system and hematopoietic system cells. It has been reported that CD10 in hair follicles is expressed in Dermal Sheath (Non-Patent Document 1: Lee et al., J. DERMATOL 2006; 155: 858-860 and Non-Patent Document 2: Poblet et al., J. DERMATOL 2008; 159: 646-652). In addition, this CD10 is a common antigen of human acute lymphoblastic leukemia and is known as human membrane-bound neutral endopeptidase (NEP).

CD13係存在於粒細胞、骨髓前驅細胞、內皮細胞、上皮細胞等中之胺肽酶-N,亦廣泛地於腎近端小管、腸、胎盤等其他組織中表現。報告有CD13於毛囊中存在於真皮毛根鞘中(非專利文獻3:Sorrel et al., Exp Dermatol 2003; 12: 315及非專利文獻4:Park et al., J Cutan Pathol. 2017; 44: 909-914.)。CD13 is an aminopeptidase-N that exists in granulocytes, bone marrow precursor cells, endothelial cells, epithelial cells, etc., and is also widely expressed in other tissues such as the proximal tubule of the kidney, intestine, and placenta. It has been reported that CD13 is present in the hair follicle in the dermal hair root sheath (Non-Patent Document 3: Sorrel et al., Exp Dermatol 2003; 12: 315 and Non-Patent Document 4: Park et al., J Cutan Pathol. 2017; 44: 909 -914.).

CD29作為整合素β1鏈為人所知。CD29可用作間葉系幹細胞之標記物,但亦於真皮毛根鞘中表現(非專利文獻5:Ernst et al., PLoS One. 2013; 8 (12))。CD29 is known as the integrin β1 chain. CD29 can be used as a marker for mesenchymal stem cells, but it is also expressed in dermal hair root sheaths (Non-Patent Document 5: Ernst et al., PLoS One. 2013; 8 (12)).

CD49b為整合素α2鏈,與整合素β1一起形成VLA-2受體。由於VLA-2會與膠原蛋白、血纖維蛋白原、層黏連蛋白等結合,故起到使各種各樣之細胞維繫在細胞外基質之作用。於文獻上眾所周知CD49b於淋巴細胞、活化T細胞單核球、上皮細胞、血小板中表現。CD49b is an integrin α2 chain, which forms the VLA-2 receptor together with integrin β1. Because VLA-2 binds to collagen, fibrinogen, laminin, etc., it plays a role in keeping various cells in the extracellular matrix. It is well known in the literature that CD49b is expressed in lymphocytes, activated T cell monocytes, epithelial cells, and platelets.

CD90係屬於免疫球蛋白超家族之GPI(Glycosyl-phosphatidylinositol,糖基磷脂醯肌醇)錨定型蛋白質,於間葉系細胞中廣泛地表現。CD90 belongs to the GPI (Glycosyl-phosphatidylinositol) anchoring protein of the immunoglobulin superfamily and is widely expressed in mesenchymal cells.

CD105亦稱為內皮糖蛋白,眾所周知作為TGF-β1與TGF-β3之受體發揮作用,且於來自脂肪之幹細胞中表現(非專利文獻6:Huang et al., Sci Rep. 2016; 6)。國際細胞治療學會於人類間葉系幹細胞之定義中採用CD90陽性及CD105陽性(非專利文獻7:Dominici et al., Cytotherapy 2006; 8: 315-317)。CD105, also known as endoglin, is known to act as a receptor for TGF-β1 and TGF-β3, and is expressed in adipose-derived stem cells (Non-Patent Document 6: Huang et al., Sci Rep. 2016; 6). The International Society for Cell Therapy uses CD90 positive and CD105 positive in the definition of human mesenchymal stem cells (Non-Patent Document 7: Dominici et al., Cytotherapy 2006; 8: 315-317).

CD274作為程序性細胞死亡配體1為人所知,係PD-1之配體之一。PD-1與PD-L1之相互作用係對T細胞之活化及耐受性起到重要作用,被稱為免疫檢查點。於2014年獲批准之納武單抗(商品名:Opdivo)係人類型抗人類PD-1單株抗體,且係免疫檢查點抑制藥之一。藉由抑制PD-1與PD-L1、PD-L2之結合而使T細胞活化,示出抗癌效果。又,於已有報告中,提示出於毛球部毛根鞘細胞中(Dermal Sheath Cup Cell:DSCC)中之表現(非專利文獻9:Wang et al., J Invest Dermatol. 2014; 134: 736-745)。CD274 is known as programmed cell death ligand 1, and is one of the ligands of PD-1. The interaction between PD-1 and PD-L1 plays an important role in the activation and tolerance of T cells, which is called immune checkpoint. Nivolumab (trade name: Opdivo) approved in 2014 is a human type of anti-human PD-1 monoclonal antibody and one of the immune checkpoint inhibitors. By inhibiting the binding of PD-1 and PD-L1 and PD-L2, T cells are activated, showing an anti-cancer effect. In addition, in an existing report, it is suggested that it is expressed in the hair bulb root sheath cell (Dermal Sheath Cup Cell: DSCC) (Non-Patent Document 9: Wang et al., J Invest Dermatol. 2014; 134: 736- 745).

NG2係別稱硫酸軟骨素蛋白多糖4(Chondroitin sulfate proteoglycan 4)之神經聚糖之一種。該NG2顯示出如下作用:在內皮之基底膜中黑色素瘤細胞進行分化、轉移時控制細胞基質之相互作用。又,提示出上述NG2係抑制軸突再生中之神經突生長及生長錐坍塌之分子。 [實施例]NG2 is a kind of neuroglycan which is also called Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan 4). The NG2 exhibits the following effects: controlling the interaction of the cell matrix when the melanoma cells differentiate and metastasize in the basement membrane of the endothelium. In addition, it is suggested that the above-mentioned NG2 is a molecule that inhibits neurite outgrowth and growth cone collapse in axon regeneration. [Example]

實施例 1 :毛球部毛根鞘細胞之識別 使用流式細胞儀(Guava 8HT-2L(MERCK MILLIPORE)),對包含毛球部毛根鞘細胞之細胞組合物進行識別。將以下之表1之抗體用於流式細胞分析。 [表1] 抗體 標記 經銷商 CD10 PE BD Bioscience CD13 PE BD Bioscience CD29 PE BD Bioscience CD49b FITC BD Bioscience CD90 FITC BD Bioscience CD105 FITC BD Bioscience CD274 FITC/PE BD Bioscience NG2 PE BD Bioscience IgG1 k PE BD Bioscience IgG1 k FITC BD Bioscience IgG2a PE BD Bioscience Example 1 : Identification of hair bulb root sheath cells A flow cytometer (Guava 8HT-2L (MERCK MILLIPORE)) was used to identify the cell composition containing hair bulb root sheath cells. The antibodies in Table 1 below were used for flow cytometric analysis. [Table 1] Antibody mark Dealer CD10 PE BD Bioscience CD13 PE BD Bioscience CD29 PE BD Bioscience CD49b FITC BD Bioscience CD90 FITC BD Bioscience CD105 FITC BD Bioscience CD274 FITC/PE BD Bioscience NG2 PE BD Bioscience IgG1 k PE BD Bioscience IgG1 k FITC BD Bioscience IgG2a PE BD Bioscience

毛球部毛根鞘細胞與角質形成細胞之分離 使用毛球部毛根鞘細胞(DSCC)、角質形成細胞、DSCC與角質形成細胞之等量混合物之3種,使細胞分別懸浮於各抗體(CD10、CD13、CD29、CD49b、CD90、CD105、CD274、NG2、及相應之同型對照(IgG1K抗體或IgG2a))之稀釋液中,並於4℃下反應30分鐘。利用PBS(Phosphate Buffered Saline,磷酸鹽緩衝生理鹽水)洗淨後於PBS中再懸浮,利用流式細胞儀進行檢測。將結果示於圖1中。於使用CD10、CD13、及CD90之情形時,角質形成細胞與DSCC顯著地分離,而能夠識別。於使用CD29、CD105及NG2之情形時,角質形成細胞與DSCC雖存在一定程度之重疊,但二者中等程度地分離,能夠大致識別。於使用CD49b及CD274之情形時,角質形成細胞與DSCC未分離。Separation of hair root sheath cells and keratinocytes in the hair bulb Using 3 types of hair bulb root sheath cells (DSCC), keratinocytes, an equal mixture of DSCC and keratinocytes, the cells were suspended in each antibody (CD10, CD13, CD29, CD49b, CD90, CD105, CD274, NG2 and the corresponding isotype control (IgG1K antibody or IgG2a)) in the dilution solution, and react at 4°C for 30 minutes. It was washed with PBS (Phosphate Buffered Saline), resuspended in PBS, and detected by flow cytometry. The results are shown in Figure 1. In the case of using CD10, CD13, and CD90, keratinocytes and DSCC are significantly separated and can be recognized. In the case of using CD29, CD105, and NG2, although keratinocytes and DSCC overlap to a certain extent, they are separated to a moderate degree and can be roughly identified. In the case of using CD49b and CD274, keratinocytes and DSCC were not separated.

毛球部毛根鞘細胞與黑色素細胞之分離 使用毛球部毛根鞘細胞(DSCC)、黑色素細胞、DSCC與黑色素細胞之等量混合物之3種,使細胞分別懸浮於各抗體(CD10、CD13、CD29、CD49b、CD90、CD105、CD274、NG2及相應之同型對照)之稀釋液中,並於4℃下反應30分鐘。利用PBS洗淨後,於PBS中再懸浮,利用流式細胞儀進行檢測。將結果示於圖2中。於使用CD13及CD90之情形時,黑色素細胞與DSCC顯著地分離,而能夠識別。於使用CD29、及CD49b之情形時,黑色素細胞與DSCC雖存在一定程度之重疊,但二者中等程度地分離,能夠大致識別。於使用CD10、CD105、CD274及NG2之情形時,黑色素細胞與DSCC未分離。Separation of hair root sheath cells and melanocytes in hair bulb Using 3 kinds of hair bulb hair root sheath cells (DSCC), melanocytes, DSCC and melanocytes, the cells were suspended in each antibody (CD10, CD13, CD29, CD49b, CD90, CD105, CD274, NG2 and Corresponding isotype control) diluted solution, and react at 4°C for 30 minutes. After washing with PBS, resuspend in PBS, and perform detection by flow cytometer. The results are shown in Figure 2. In the case of using CD13 and CD90, melanocytes and DSCC are significantly separated and can be recognized. In the case of using CD29 and CD49b, although there is a certain degree of overlap between melanocytes and DSCC, the two are separated to a moderate degree and can be roughly identified. When using CD10, CD105, CD274 and NG2, melanocytes and DSCC were not separated.

實施例2:再現性之確認 使用DSCC、角質形成細胞、黑色素細胞之3種,使細胞懸浮於CD13、CD29、CD90及相應之同型對照之各抗體之稀釋液中,並於4℃下反應30分鐘。利用PBS洗淨後,於PBS中再懸浮,並利用流式細胞儀進行檢測。將結果示於圖3A,將重疊柱狀圖而成之圖示於圖3B。CD13、CD29及CD90之全部抗體可將DSCC與角質形成細胞、及黑色素細胞分離而檢測出。Example 2: Confirmation of reproducibility Using 3 types of DSCC, keratinocytes, and melanocytes, the cells were suspended in the dilutions of each antibody of CD13, CD29, CD90 and the corresponding isotype control, and reacted at 4°C for 30 minutes. After washing with PBS, resuspend in PBS, and use flow cytometer for detection. The results are shown in FIG. 3A, and the graph formed by overlapping the histograms is shown in FIG. 3B. All antibodies against CD13, CD29 and CD90 can be detected by separating DSCC from keratinocytes and melanocytes.

實施例3:雙重染色之研究 使用2個批次之DSCC,使細胞懸浮於CD13抗體(PE標記)、CD90抗體(FITC標記)、及CD13抗體(PE標記)+CD90抗體(FITC標記)之稀釋液中,並於4℃下反應30分鐘,進行單染色及雙重染色。利用PBS洗淨後,於PBS中再懸浮,利用流式細胞儀進行檢測。於實施流式細胞儀後,使用單染色之資料對FITC向PE檢測系統中之逸漏進行修正。將結果示於圖4及5中。示出藉由CD13之單染色(A)、D90之單染色(B)、及CD13及CD90之雙重染色(C)而判斷為DSCC之細胞之比率。又,針對相同批次之DSCC進行先前所進行之角質形成細胞否定試驗。於角質形成細胞否定試驗中,判定角質形成細胞之比率為0.16%、0.05%。因此,若將除角質形成細胞以外假定為DSCC,則DSCC之比率會變成99.84%、99.95%,單染色及雙重染色之結果為,示出與先前試驗大致同等之DSCC比率。Example 3: Study of double staining Use 2 batches of DSCC to suspend the cells in the dilutions of CD13 antibody (PE labeled), CD90 antibody (FITC labeled), and CD13 antibody (PE labeled) + CD90 antibody (FITC labeled) at 4°C React for 30 minutes for single staining and double staining. After washing with PBS, resuspend in PBS, and perform detection by flow cytometer. After implementing the flow cytometer, use the single staining data to correct the leakage of FITC to the PE detection system. The results are shown in Figures 4 and 5. It shows the ratio of cells judged to be DSCC by CD13 single staining (A), D90 single staining (B), and CD13 and CD90 double staining (C). In addition, the previous negative test of keratinocytes was performed on the same batch of DSCC. In the negative test of keratinocytes, the ratio of keratinocytes was determined to be 0.16% and 0.05%. Therefore, assuming that the keratinocytes other than keratinocytes are DSCC, the ratio of DSCC will become 99.84% and 99.95%. The results of single staining and double staining show that the ratio of DSCC is approximately the same as in the previous experiment.

實施例4:DSCC檢測力之驗證 使用3個批次之DSCC並混入5%、10%、及20%之角質形成細胞而獲得細胞組合物,使所得之細胞組合物分別懸浮於CD90抗體(FITC標記)之稀釋液中,於4℃下反應30分鐘,進行單染色。利用PBS洗淨後於PBS中再懸浮,利用流式細胞儀進行檢測,將檢測所得之結果示於圖6中。圖6E係角質形成細胞混入率20%(A)、10%(B)、5%(C)、及0%(D)時之流式細胞儀之結果,並將CD90陽性之細胞率示於圖6E中。Example 4: Verification of the detection power of DSCC Use 3 batches of DSCC and mix 5%, 10%, and 20% of keratinocytes to obtain a cell composition. The resulting cell composition is suspended in a dilution of CD90 antibody (FITC labeled) for 4 React for 30 minutes at °C for single dyeing. After washing with PBS, it was resuspended in PBS, and detected by flow cytometry. The results of the detection are shown in FIG. 6. Figure 6E shows the results of flow cytometry when the keratinocyte incorporation rate is 20% (A), 10% (B), 5% (C), and 0% (D), and the CD90-positive cell rate is shown in Figure 6E.

圖1係表示使用細胞表面標記物對毛球部毛根鞘細胞(DSCC)與角質形成細胞(KC)之識別可能性進行研究所得之流式細胞分析的結果。Mix表示將DSCC與KC以1:1進行混合而成之樣本之結果。實線表示使用各抗體之情形時之分佈,虛線表示使用與各自相對應之同型對照抗體之情形時之分佈。 圖2係表示使用細胞表面標記物對毛球部毛根鞘細胞(DSCC)與黑色素細胞(MC)之識別可能性進行研究所得之流式細胞分析的結果。Mix表示將DSCC與MC以1:1進行混合而成之樣本之結果。實線表示使用各抗體之情形時之分佈,虛線表示使用與各自相對應之同型對照抗體之情形時之分佈。 圖3係表示流式細胞分析之結果(A),該流式細胞分析之結果顯示細胞表面標記物(CD13、CD29及CD90)分別識別出毛球部毛根鞘細胞(DSCC)、與角質形成細胞(KC)及黑色素細胞(MC)。圖3B係表示重疊圖3A之DSCC、KC及MC時所獲得之圖而成之圖。實線表示使用各抗體之情形時之分佈,虛線表示使用與各自相對應之同型對照抗體之情形時之分佈。 圖4係表示對經CD90及CD13雙重染色之毛球部毛根鞘細胞(DSCC)進行流式細胞分析之結果(A及B)。實線表示使用各抗體之情形時之分佈,虛線表示使用與各自相對應之同型對照抗體之情形時之分佈。圖4C係表示CD13與CD90為雙重陽性之細胞之集合。 圖5係表示以與圖4相同之方法但使用不同批次之DSCC所獲得之結果(A-C)。實線表示使用各抗體之情形時之分佈,虛線表示使用與各自相對應之同型對照抗體之情形時之分佈。 圖6係對於DSCC混入角質形成細胞20%(A)、10%(B)、5%(C)、0%(D),進行使用CD90之流式細胞分析所得的結果。實線表示使用各抗體之情形時之分佈,虛線表示使用與各自相對應之同型對照抗體之情形時之分佈。圖6E係表示CD90陽性之細胞率。Figure 1 shows the results of flow cytometry analysis using cell surface markers to study the possibility of identifying hair bulb root sheath cells (DSCC) and keratinocytes (KC). Mix represents the result of a sample that mixes DSCC and KC at a ratio of 1:1. The solid line represents the distribution when each antibody is used, and the dotted line represents the distribution when the corresponding isotype control antibody is used. Figure 2 shows the results of flow cytometry analysis using cell surface markers to study the possibility of identifying hair bulb root sheath cells (DSCC) and melanocytes (MC). Mix represents the result of a sample made by mixing DSCC and MC at a ratio of 1:1. The solid line represents the distribution when each antibody is used, and the dotted line represents the distribution when the corresponding isotype control antibody is used. Figure 3 shows the results of flow cytometry analysis (A). The results of the flow cytometry analysis show that cell surface markers (CD13, CD29, and CD90) respectively identify hair bulb root sheath cells (DSCC) and keratinocytes (KC) and melanocytes (MC). Fig. 3B is a graph obtained by superimposing the DSCC, KC, and MC of Fig. 3A. The solid line represents the distribution when each antibody is used, and the dotted line represents the distribution when the corresponding isotype control antibody is used. Figure 4 shows the results (A and B) of flow cytometric analysis of hair bulb root sheath cells (DSCC) double-stained for CD90 and CD13. The solid line represents the distribution when each antibody is used, and the dotted line represents the distribution when the corresponding isotype control antibody is used. Figure 4C shows a collection of CD13 and CD90 double positive cells. Figure 5 shows the results (A-C) obtained by the same method as Figure 4 but using different batches of DSCC. The solid line represents the distribution when each antibody is used, and the dotted line represents the distribution when the corresponding isotype control antibody is used. Figure 6 shows the results of flow cytometric analysis using CD90 for 20% (A), 10% (B), 5% (C), and 0% (D) of DSCC mixed with keratinocytes. The solid line represents the distribution when each antibody is used, and the dotted line represents the distribution when the corresponding isotype control antibody is used. Figure 6E shows the rate of CD90-positive cells.

Claims (12)

一種鑑定毛球部毛根鞘細胞之方法,其係於包含毛球部毛根鞘細胞之細胞組合物中鑑定毛球部毛根鞘細胞之方法,該方法包括對選自由CD13、CD90、CD10、CD29、CD105、CD49b及NG2所組成之群中之至少1種細胞表面標記物進行檢測。A method for identifying hair bulb root sheath cells, which is a method for identifying hair bulb root sheath cells in a cell composition comprising hair bulb root sheath cells. The method includes selecting from the group consisting of CD13, CD90, CD10, CD29, At least one cell surface marker in the group consisting of CD105, CD49b and NG2 is tested. 如請求項1之方法,其中上述細胞表面標記物係選自由CD13、CD90、CD10、CD29、CD105、及NG2所組成之群,且識別毛球部毛根鞘細胞而與上述細胞組合物中所包含之角質形成細胞區分開。The method of claim 1, wherein the cell surface marker is selected from the group consisting of CD13, CD90, CD10, CD29, CD105, and NG2, and the hair bulb root sheath cell is recognized and is included in the cell composition The keratinocytes are distinguished. 如請求項1之方法,其中上述細胞表面標記物係選自由CD13、CD90、CD29、及CD49b所組成之群,且識別毛球部毛根鞘細胞與上述細胞組合物中所包含之黑色素細胞區分開。The method of claim 1, wherein the cell surface marker is selected from the group consisting of CD13, CD90, CD29, and CD49b, and the hair bulb root sheath cells are distinguished from the melanocytes contained in the cell composition . 如請求項1之方法,其中上述細胞表面標記物係選自由CD13、CD90、及CD29所組成之群,且識別毛球部毛根鞘細胞而與上述細胞組合物中所包含之黑色素細胞及角質形成細胞區分開。The method according to claim 1, wherein the cell surface marker is selected from the group consisting of CD13, CD90, and CD29, and the hair bulb root sheath cells are recognized to form the melanocytes and keratinocytes contained in the cell composition. Cell differentiation. 如請求項1至4中任一項之方法,其中上述細胞表面標記物係選自由CD13及CD90所組成之群。The method according to any one of claims 1 to 4, wherein the cell surface marker is selected from the group consisting of CD13 and CD90. 如請求項1至5中任一項之方法,其中上述細胞表面標記物係藉由流式細胞分析來檢測。The method according to any one of claims 1 to 5, wherein the above-mentioned cell surface marker is detected by flow cytometry. 如請求項1至6中任一項之方法,其中上述細胞組合物係用於毛髮再生之細胞組合物。The method according to any one of claims 1 to 6, wherein the above-mentioned cell composition is a cell composition for hair regeneration. 如請求項1至7中任一項之方法,其中上述細胞組合物包含經過培養之毛球部毛根鞘細胞。The method according to any one of claims 1 to 7, wherein the above-mentioned cell composition comprises cultured hair bulb root sheath cells. 如請求項1至8中任一項之方法,其中細胞組合物係冷凍保存前或冷凍保存後之細胞組合物。The method according to any one of claims 1 to 8, wherein the cell composition is a cell composition before or after cryopreservation. 如請求項9之方法,其中細胞組合物係冷凍保存後之細胞組合物。The method of claim 9, wherein the cell composition is a cell composition after cryopreservation. 一種確定細胞組合物之品質之方法,其藉由如請求項1至10中任一項之方法,於包含毛球部毛根鞘細胞之細胞組合物中鑑定毛球部毛根鞘細胞,藉此確定細胞組合物之品質。A method for determining the quality of a cell composition by identifying hair bulb root sheath cells in a cell composition containing hair bulb root sheath cells by the method according to any one of claims 1 to 10, thereby determining The quality of the cell composition. 一種品質得到管理之細胞組合物之製造方法,其包括以下步驟: 藉由如請求項11之確定細胞組合物之品質之方法來確定包含毛球部毛根鞘細胞之細胞組合物之品質,並且 除去規定品質以下之細胞組合物。A method for manufacturing a cell composition with managed quality, which includes the following steps: The quality of the cell composition containing the hair bulb root sheath cells is determined by the method for determining the quality of the cell composition as in claim 11, and Remove the cell composition below the specified quality.
TW109124757A 2019-07-22 2020-07-22 Method for identifying dermal sheath cup cells TW202119028A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019134854 2019-07-22
JP2019-134854 2019-07-22

Publications (1)

Publication Number Publication Date
TW202119028A true TW202119028A (en) 2021-05-16

Family

ID=74194211

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109124757A TW202119028A (en) 2019-07-22 2020-07-22 Method for identifying dermal sheath cup cells

Country Status (4)

Country Link
JP (1) JPWO2021015209A1 (en)
CN (1) CN114158274A (en)
TW (1) TW202119028A (en)
WO (1) WO2021015209A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022191149A1 (en) * 2021-03-10 2022-09-15 株式会社 資生堂 Method for identifying cell capable of regenerating follicles, and method for evaluating composition for follicle regeneration use
KR20240019341A (en) * 2021-07-15 2024-02-14 후지필름 가부시키가이샤 Cell quality control methods and cell manufacturing methods
WO2023286305A1 (en) * 2021-07-15 2023-01-19 富士フイルム株式会社 Cell quality management method and cell production method
WO2023171395A1 (en) * 2022-03-09 2023-09-14 株式会社 資生堂 Method for evaluating hair regeneration capability of cell population containing mesenchymal cells
WO2023210402A1 (en) * 2022-04-28 2023-11-02 株式会社 資生堂 Method for evaluating hair regeneration ability of dermal sheath cup (dsc) cells, composition for hair regeneration and manufacturing method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10224982A1 (en) * 2002-06-05 2003-12-24 Rolf Hoffmann Mesenchymal stem cells of the hair follicle and their use

Also Published As

Publication number Publication date
WO2021015209A1 (en) 2021-01-28
CN114158274A (en) 2022-03-08
JPWO2021015209A1 (en) 2021-01-28

Similar Documents

Publication Publication Date Title
TW202119028A (en) Method for identifying dermal sheath cup cells
Andrews et al. Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies
Triel et al. Side population cells in human and mouse epidermis lack stem cell characteristics
Ohyama et al. Characterization and isolation of stem cell–enriched human hair follicle bulge cells
Foster et al. Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor.
JP3070865B2 (en) Subset of human progenitor cells
Seach et al. Purified enzymes improve isolation and characterization of the adult thymic epithelium
US7718376B2 (en) Identification and isolation of somatic stem cells and uses thereof
US20200209240A1 (en) Cd19cart cells eliminate myeloma cells that express very low levels of cd19
US20230258645A1 (en) Antxr1 as a biomarker of immunosuppressive fibroblast populations and its use for predicting response to immunotherapy
Favrot et al. Expression of integrin receptors on 45 clinical neuroblastoma specimens
Burrows et al. The role of integrins in adhesion of decidual NK cells to extracellular matrix and decidual stromal cells
Sharpe et al. Isolation of endothelial colony-forming cells from blood samples collected from the jugular and cephalic veins of healthy adult horses
US20020102244A1 (en) Method of identifying and/or isolating stem cells and prognosing responsiveness to leukemia treatment
WO2020252444A1 (en) Three-dimensional cross-linked scaffolds of peripheral blood plasma and their use
Heinrich et al. Immunophenotyping of immune cell populations in the raccoon (Procyon lotor)
CN102260647A (en) Method for isolating and purifying breast cancer stem cells
US20210270812A1 (en) Method for analyzing immune cells
JPWO2004005496A1 (en) Novel undifferentiated stem cell population contained in umbilical cord blood, bone marrow, peripheral blood, etc.
US20120128632A1 (en) Identity markers
Butucescu et al. The oral mucosa: Epithelial professional phagocytes, lymphatics, telocytes, and false telocytes
Stewart et al. Monoclonal antibodies to cultured human glomerular mesangial cells. I. Reactivity with haematopoietic cells and normal kidney sections
Bender et al. Flow cytometric analysis of human bone marrow
Pronk et al. Immunophenotypic identification of early myeloerythroid development
Pessa-Morikawa et al. Fetal bovine bone marrow is a rich source of CD34+ hematopoietic progenitors with myelo–monocytic colony-forming activity